Practical experience with intensity-modulated radiotherapy

British Journal of Radiology

Volumn 77, Issue 913, 2004, Pages 3-14

  James, H V ^a   Scrase, C D ^a   Poynter, A J ^a  

^a IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CAMERA; COLLIMATOR; COMPUTER ASSISTED RADIOTHERAPY; DOSIMETRY; FLUOROSCOPY; GENERAL HOSPITAL; HUMAN; IN VIVO STUDY; INTENSITY MODULATED RADIATION THERAPY; LINEAR ACCELERATOR; LUNG NON SMALL CELL CANCER; PATIENT SELECTION; QUALITY CONTROL; RADIATION DOSE FRACTIONATION; REVIEW; STATISTICAL ANALYSIS; TREATMENT PLANNING;

CLINICAL COMPETENCE; ENGLAND; FORECASTING; HEAD AND NECK NEOPLASMS; HOSPITALS, DISTRICT; HUMANS; IMAGING, THREE-DIMENSIONAL; MEDICAL AUDIT; MEDICAL STAFF, HOSPITAL; PALLIATIVE CARE; PATIENT SELECTION; QUALITY ASSURANCE, HEALTH CARE; RADIOLOGY; RADIOLOGY DEPARTMENT, HOSPITAL; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL;

EID: 1242296349     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/14996943     Document Type: Review

References (58)

1. Takahashi S. Conformation radiotherapy: rotation techniques as applied to radiography and radiotherapy of cancer. Acta Radiol Suppl 1965;242:1-42.
2. Convery DJ, Rosenbloom ME. The generation of intensity-modulated fields for conformal radiotherapy by dynamic collimation. Phys Med Biol 1992;37:1359-71.
3. De Neve W, De Wagter C, De Jaeger K, Thienpont M, Colle C, Derycke S, et al. Planning and delivering high doses to targets surrounding the spinal cord at the lower neck and upper mediastinal levels: static beam segementation technique executed with a multi-leaf collimator. Radiother Oncol 1996;40:271-9.
4. Mackie TR, Holmes T, Swerdloff S, Rockwerdt P, Deasy JO, Yang J, et al. Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. Med Phys 1993;20:1709-19.
5. RCR/IPEM/COR. Development and implementation of conformal radiotherapy in the United Kingdom. London: The Royal College of Radiologists, 2002.
6. Kam MKM, Chau RMC, Suen J, Choi PHK, Teo PML. Intensity-modulated radiotherapy in nasopharygeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys 2003;56:145-57.
7. Xia P, Fu KK, Wong GW, Akazawa C, Verhey LJ. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2000;48:329-37.
8. Huang D, Xia P, Akazawa P, Akazawa C, Quivey JM, Verhey LJ, et al. Comparison of treatment plans using intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for paranasal sinus carcinoma. Int Radiat Oncol Biol Phys 2003;56:158-68.
9. Claus F, De Gersem W, De Wagter C, Van Severen R, Vanhoutte I, Duthoy W, et al. An implementation strategy for IMRT of ethmoid sinus cancer with bilateral sparing of the optic pathways. Int J Radiat Oncol Biol Phys 2001;51:318-31.
10. Adams EJ, Nutting CM, Convery DJ, Cosgrove VP, Henk JM, Dearnaley DP, et al. Potential role of intensity-modulated radiotherapy in the treatment of tumors of the maxillary sinus. Int J Radiat Oncol Biol Phys 2001;51:579-88.
11. Nutting CM, Convery DJ, Cosgrove VP, Rowbottom C, Vini L, Harmer C, et al. Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland. Radiother Oncol 2001;60:173-80.
12. Zabel A, Thilmann C, Zuna I, Schlegel W, Wannenmacher M, Debus J. Comparison of forward planned conformal radiation therapy and inverse planned intensity modulated radiation therapy for esthesioneuroblastoma. Br J Radiol 2002;75:356-61.
13. Bragg CM, Conway J, Robinson MH. The role of intensity-modulated radiotherapy in the treatment of parotid tumors. Int J Radiat Oncol Biol Phys 2002;52:729-38.
14. Budgell GJ, Mott JHL, Logue JP, Hounsell AR. Clinical implementation of dynamic multileaf collimation for compensated bladder treatments. Radiother Oncol 2001;59:31-8.
15. Vicini FA, Sharpe M, Kostin L, Martinez A, Mitchell CK, Wallace M, et al. Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2002;54:1336-44.
16. Donovan EM, Bleackley NI, Evans PM, Reise SF, Yarnold JR. Dose position and dose-volume histogram analysis of standard wedged and intensity modulated treatments in breast radiotherapy. Br J Radiol 2002;75:967-73.
17. Dearnaley D. Modern external beam radiotherapy. Radiother Oncol 1998;48 Suppl 1:S2.
18. MRC Radiotherapy Working Party. Clinical Protocol RT01. A randomised trial of high dose therapy in localised cancer of the prostate using conformal radiotherapy techniques. London: Medical Research Council, 1998.
19. Spirou SV, Chui CS. A gradient inverse planning algorithm with dose volume constraints. Med Phys 1998;25:321-33.
20. Haas B, Mey L, Andre L. Generation of inhomogeneous irradiation fields by dynamic control of multileaf collimators. University of Bern: MSc Thesis, 1996.
21. LoSasso T, Chui C, Ling CC. Physical and dosimetric aspects of a multileaf collimation system used in the dynamic mode for implementing intensity modulated radiotherapy. Med Phys 1998;25:1919-27.
22. Venables K, Deighton A, Winfield E, Aird E, Hoskin P. Breast radiotherapy phantom design for the START trial. START Trial Management Group. Br J Radiol 2000;73:1313-6.
23. Chui CS, Spirou S, LoSasso T. Testing of dynamic multileaf collimation. Med Phys 1996;23:635-41.
24. Ting J, Davis L. Dose verification for patients undergoing IMRT. Med Dosim 2001;26:205-13.
25. McJury M, Nakielny R, Levy D, Conway J, Lilley J, Robinson MH. Differences in target localisation and plan quality with the use of intravenous contrast in head and neck cancer: some initial findings. Radiother Oncol 2000;56 Suppl 1:S157.
26. http://groups.eortc.be/home/radio/ATLAS.htm
27. Scrase CD, Poynter AJ, James HV, Allen O. Introducing CT-based planning for head and neck radiotherapy. Clin Oncol (R Coll Radiol) 2001;13 Suppl 2:S9.
28. RCR/COR/RCN/IPEM. Breaking the mould: roles, responsibilities and skills mix in departments of clinical oncology. London: The Royal College of Radiologists, 2002.
29. Pignon JP, Bourhis J, Domenge C, Designé L. (MACH-NC). Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. The Lancet 2000;355:949-55.
30. Bourhis J, Syz N, Overgaard J, Ang KK, Dische S, Horiot JC, et al. Conventional versus modified fractionated radiotherapy: meta-analysis based on individual data of patients with head and neck squamous cell carcinoma (HNSCC). Radiother Oncol 2002;64 Suppl 1:S25.
31. Bernier J, Bentzen SM. Altered fractionation and combined radio-chemotherapy approaches: pioneering new opportunities in head and neck oncology. Eur J Cancer 2003;39:560-71.
32. Erridge SC, Robar JL, Wu JS. The use of electronic compensation with MLC in wide field irradiation for head and neck cancers. Clin Oncol (R Coll Radiol) 2003;15 Suppl 2:S13.
33. Pirzkall A, Lohr F, Rhein B, Hoss A, Schlegel W, Wannenmacher M, et al. Conformal radiotherapy of challenging paraspinal tumours using a multiple arc segment technique. Int J Radiat Oncol Biol Phys 2000;48:1197-204.
34. START Trial Management Group. Standardisation of Breast Radiotherapy (START). A randomised comparison of fractionation regimens after local excision or mastectomy in women with early stage breast cancer. Final Protocol - July 1998. The Institute of Cancer Research, UK.
35. James HV, Poynter AJ, Crosbie JC, MacKenzie LC, Boston SL, Le Vay J. Electronic compensation for CT planned breast treatments. Radiother Oncol 2002;64:S133.
36. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109-22.
37. Fowler JF, Bentzen SO, Bond SJ, Ang KK, van der Kogel AJ, Van den Bogaert W, et al. Clinical radiation doses for spinal cord: the 1998 international questionnaire. Int J Radiat Oncol Biol Phys 2000;55:295-300.
38. Gregoire V, Coche E, Cosnard G, Hamoir M, Reychler H. Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol 2000;56:135-50.
39. Nowak PJCM, Wijers OB, Lagerwaard FJ, Levendag PC. A three-dimensional CT-based target definition for elective irradiation of the neck. Int J Radiat Oncol Biol Phys 1999;45:33-9.
40. Wijers OB, Levendag PC, Tan T, van Dieren EB, van Sörnsen de Koste J, van der Est H, et al. A simplified CT-based definition of the lymph node levels in the node negative neck. Radiother Oncol 1999;52:35-42.
41. Maes A, Weltens C, Flamen P, Lambin P, Bogaerts R, Liu X, et al. Preservation of parotid function with uncomplicated conformal radiotherapy. Radiother Oncol 2002;63:203-11.
42. Henson BS, Inglehart MR, Eisbruch A, Ship JA. Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy. Oral Oncol 2001;37:84-93.
43. Changlia SP, Chen WK, Chung C, Chiou SM. Objective evidence of decreased salivary function in patients with autoimmune thyroiditis (chronic thyroiditis, Hashimoto's thyroiditis). Nuclear Medicine Communications 2002;23:1029-33.
44. Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999;45:577-87.
45. Lee N, Chuang C, Quivey JM, Phillips TL, Akazawa P, Verhey L, et al. Skin toxicity due to intensity-modulated radiotherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 2002;53:630-7.
46. Claus F, Boterberg T, Ost P, De Neve W. Short term toxicity profile for 32 sinonasal cancer patients treated with IMRT: can we avoid dry eye syndrome? Radiother Oncol 2002;64:205-8.
47. Hernando ML, Marks LB, Bentel GC, Zhou S-M, Hollis D, Das SK, et al. Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 2001;51:650-9.
48. Le Vay JH, James HV, Poynter AJ, Mackenzie LC, Boston SL. Optimising the delivery of radiotherapy for early breast cancer by the use of IMRT. Clin Oncol 2003;15:S14.
49. Kouloulias VE, Poortmans PM, Bernier J, Horiot J-C, Johansson K-A, Davis B, et al. The quality assurance programme of the radiotherapy group of the European Organization for Research and Treatment of Cancer (EORTC): a critical appraisal of 20 years of continuous efforts. Eur J Cancer 2003;39:430-7.
50. Butler EB, Teh BS, Grant WH III, Uhl BM, Kuppersmith RB, Chin JK, et al. SMART (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head-and-neck cancer with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 1999;45:21-32.
51. Amosson CM, Teh BS, Van TJ, Uy N, Huang E, Mai W-Y, et al. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the SMART (simultaneous modulated accelerated radiation therapy) boost technique. Int J Radiat Oncol Biol Phys 2003;56:136-44.
52. Zelefsky MJ, Fuks Z, Happersett L, Lee HJ, Ling CC, Burman CM. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 2000;55:241-9.
53. Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomised study. Int J Radiat Oncol Biol Phys 2002;53:1097-105.
54. Corletto D, Iori M, Paiusco M, Brait S, Broggi G, Ceresoli G, et al. Inverse and forward optimisation of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer. Radiother Oncol 2003;66:185-95.
55. Ahamad A, Stevens CW, Smythe WR, Vaporciyan AA, Komaki R, Kelly JF, et al. Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2003;55:768-75.
56. Forster KM, Smythe WR, Starkschall G, Laio Z, Takanaka T, Kelly JF, et al. Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation. Int J Radiat Oncol Biol Phys 2003;55:606-16.
57. Milker-Zabel S, Zabel A, Thilmann C, Schlegel W, Wannenmacher M, Debus J. Clinical results of retreatment of vertebral bone metastases by stereotactic conformal radiotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2003;55:162-7.
58. Stein J, Mohan R, Wang X, Bortfeld T, Wu Q, Preiser K, et al. Number and orientations of beams in intensity-modulated radiation treatments. Med Phys 1997;24:149-60.